Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect
- 16 September 2004
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 368 (1), 82-86
- https://doi.org/10.1016/j.neulet.2004.06.060
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Repeated treatment with the synthetic cannabinoid WIN 55,212‐2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic painBritish Journal of Pharmacology, 2004
- Antinociceptive Effect of Morphine, but not μ Opioid Receptor Number, Is Attenuated in the Spinal Cord of Diabetic RatsAnesthesiology, 2003
- Topical cannabinoid antinociception: synergy with spinal sitesPain, 2003
- Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistryNeuroscience, 2003
- ‘Knock-down’ of spinal CB1 receptors produces abnormal pain and elevates spinal dynorphin content in micePain, 2002
- Hypersensitivity of Spinothalamic Tract Neurons Associated With Diabetic Neuropathic Pain in RatsJournal of Neurophysiology, 2002
- Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the ratPain, 1999
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994
- Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanismsNeurology, 1994
- Efficient Analysis of Experimental ObservationsAnnual Review of Pharmacology and Toxicology, 1980